Top Page
Menicon Co
(Frankfurt:7780)
Menicon Co (7780) vs. iShares MSCI Japan ETF (EWJ)
Menicon Co Business Overview & Revenue Model
Menicon Co Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.49B | 121.49B | 116.19B | 110.19B | 100.17B | 86.21B |
| Gross Profit | 65.08B | 65.08B | 61.01B | 58.48B | 52.88B | 45.82B |
| EBITDA | 18.52B | 18.52B | 15.74B | 19.33B | 17.52B | 14.61B |
| Net Income | 5.62B | 5.62B | 4.54B | 7.38B | 6.48B | 5.95B |
Balance Sheet | ||||||
| Total Assets | 187.28B | 187.28B | 179.81B | 152.52B | 130.98B | 126.73B |
| Cash, Cash Equivalents and Short-Term Investments | 42.05B | 42.05B | 46.91B | 41.28B | 33.05B | 41.45B |
| Total Debt | 75.09B | 75.09B | 70.79B | 53.58B | 42.44B | 45.30B |
| Total Liabilities | 101.12B | 101.12B | 98.01B | 77.86B | 63.94B | 65.75B |
| Stockholders Equity | 86.10B | 86.10B | 81.75B | 74.61B | 66.99B | 60.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -77.00M | -9.47B | -226.00M | -3.23B | -1.25B |
| Operating Cash Flow | 0.00 | 13.94B | 11.87B | 12.75B | 12.72B | 10.63B |
| Investing Cash Flow | 0.00 | -19.66B | -21.57B | -13.78B | -16.15B | -15.63B |
| Financing Cash Flow | 0.00 | 714.00M | 14.55B | 8.90B | -5.40B | 28.91B |
Menicon Co Technical Analysis
Menicon Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥90.45B | 18.62 | 6.01% | 2.35% | 3.13% | 2.91% | |
51 Neutral | $7.92B | -0.36 | -43.38% | 2.24% | 22.38% | -2.16% | |
| ― | $1.61B | 20.35 | 29.03% | 2.77% | ― | ― | |
75 Outperform | ¥57.61B | 14.17 | 2.68% | 12.18% | 34.17% | ||
72 Outperform | ¥69.90B | 17.19 | 2.50% | 6.82% | -1.08% | ||
67 Neutral | ¥16.62B | 14.91 | 2.73% | 2.38% | -48.68% | ||
60 Neutral | ¥19.01B | 13.81 | 2.33% | 11.12% | 20.54% |
Menicon Co Corporate Events
Menicon Co., Ltd. announced an interim report on its share buyback program, which was resolved at a board meeting on June 19, 2025. As of August 31, 2025, the company has repurchased 1,691,200 common shares for a total of JPY 1,962,429,600. This move is part of a larger plan to buy back up to 2,300,000 shares, representing 3.0% of total issued shares, with a maximum allocation of JPY 2,400 million. The buyback is conducted through market purchases on the Tokyo Stock Exchange and is expected to impact the company’s stock value and shareholder returns positively.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen1355.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. reported a slight increase in revenue for its Vision Care business in the first quarter of FY2025, despite a decline in operating profit due to supply constraints and upfront costs for a new plant in Malaysia. The company remains optimistic about meeting its full-year forecast, driven by domestic price revisions and expanded supply capacity. In the orthokeratology-related market, Menicon plans to introduce new products and marketing strategies to maintain its leading position in China and capture growth opportunities in other regions. The impact of U.S. tariffs is expected to be limited due to the small revenue share from North America. Menicon has also initiated a share buyback program, reflecting its belief in the undervaluation of its stock and commitment to enhancing shareholder returns.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. reported its consolidated financial results for the three months ended June 30, 2025, showing a slight increase in net sales by 0.3% compared to the previous year. However, the company experienced significant declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 26.9%, 35.6%, and 43.8% respectively. The company’s comprehensive income also dropped by 76.7%. Despite these challenges, Menicon maintained its financial forecast for the fiscal year ending March 31, 2026, with expectations of a 2.9% increase in net sales and a 1.9% rise in operating profit. The company’s capital adequacy ratio improved slightly from 45.4% to 46.1%, indicating a stable financial position.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced the issuance of share remuneration-type stock options to its executive officers, directors, employees, and subsidiaries’ directors. This move, decided in a board meeting on June 26, 2025, involves the allocation of share acquisition rights across various groups within the company, aiming to align the interests of its stakeholders with the company’s performance. The stock options are structured such that recipients can offset the cash payment obligation with their remuneration claims, thus enhancing the company’s incentive structure.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen1400.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced an interim report on its share buyback program, which was resolved at a board meeting on June 19, 2025. The company has bought back 284,900 common shares for JPY 305,168,900 between June 20 and June 30, 2025, as part of a broader plan to repurchase up to 2.3 million shares by December 20, 2025. This move is aimed at enhancing shareholder value and optimizing capital structure.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced the issuance of share remuneration-type stock options to directors and employees of its subsidiaries, aiming to enhance motivation and contribute to the sustained improvement of the company’s business performance. This strategic move is expected to promote management efforts to increase corporate value, potentially impacting the company’s operational dynamics and stakeholder interests.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced the issuance of share remuneration-type stock options to directors of its subsidiaries in Japan. This move is aimed at enhancing motivation and aligning the interests of directors with the company’s long-term goals, thereby promoting sustained improvement in business performance and corporate value.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced the issuance of share remuneration-type stock options to its executive officers, directors, and employees to enhance motivation and contribute to the company’s sustained business performance and corporate value. This strategic move aims to align the interests of key personnel with the company’s long-term goals, potentially impacting its operational efficiency and market positioning positively.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced a share buyback program, resolving to repurchase up to 2.3 million shares, which is 3% of its total issued shares, at a maximum cost of JPY 2.4 billion. This decision is part of a broader strategy to enhance shareholder value while addressing the current stock price, which the company believes does not reflect its future profitability. The buyback will be funded from cash on hand and is aligned with Menicon’s medium-term management plan, which includes expanding production capacity to meet the growing demand for daily disposable contact lenses. The company’s new plant in Malaysia is expected to significantly boost supply capacity by March 2026, contributing to economies of scale and improved business performance.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.